Hook and thesis
MakeMyTrip (MMYT) has been under pressure since a March short-seller report highlighted alleged regulatory and accounting problems, and the market has punished the stock accordingly. That sell-off pushed MMYT from its 52-week high of $104.99 to the mid-$40s, leaving valuation multiples that look demanding on paper but attractive on a tactical basis if you believe the headline-driven weakness is temporary.
My view: the short-term pain is largely event-driven and already reflected in the price. The company remains India’s largest online travel agency with a diversified revenue mix (air, hotels, packages, corporate travel), a fresh product push including an AI tie-up, and an acquisition that strengthens corporate offerings. For active traders and risk-tolerant investors, buying a disciplined dip around $46.16 offers a favorable asymmetric trade. I lay out a mid-term trade plan (45 trading days) below, describe the underlying fundamentals and valuation, and list catalysts and risks that will determine whether this trade works.
What MakeMyTrip does - and why the market should care
MakeMyTrip operates an end-to-end travel platform in India and adjacent markets. Its product set includes air ticketing, hotels and packages, rail and bus tickets, car hire, experiences, and corporate travel solutions. That breadth matters: leisure recovery and corporate travel trends drive different revenue levers - air and hotels volume on the consumer side and higher-margin services and corporate spend on the enterprise side. The company has also been consolidating corporate capability via acquisitions to capture higher-value, repeat clients.
Travel is cyclical, but India is underpenetrated versus western markets. When consumer discretionary spending and business travel reaccelerate, the platform effect and scale benefits tend to compound profitability - which is why the market pays a premium multiple for growth names in the space. That premium can be volatile when headlines, regulation, or macro slowdowns hit short-term booking volumes.
Where the company sits today - key numbers
- Current price: $46.16 (recent close near this level).
- Market cap: roughly $4.38 billion.
- 52-week range: $32.67 - $104.99.
- Profitability signals: return on assets -17.94%, return on equity -37.04%.
- Liquidity and leverage: reported current ratio ~1.01 and debt-to-equity at 0 (net leverage appears manageable on reported figures).
- Valuation multiples: price-to-sales ~14.26 and enterprise-value-to-sales ~14.11, indicating the market expects durable growth and high margin expansion to justify the price.
Those numbers tell a mixed story. On one hand, ROA and ROE are negative today, reflecting post-investment or temporary margin pressure. On the other hand, low reported leverage and a current ratio around 1.0 mean the company is not balance-sheet constrained. The market cap of ~$4.38B prices in a lot of future growth, which is precisely why volatility around regulatory headlines can create buying opportunities for investors who believe the core economics will normalize.
Technical and sentiment backdrop
From a technical perspective, MMYT is trading slightly above its 50-day average ($45.39) and about in line with short-term EMAs (EMA9 ~$44.91, EMA21 ~$44.56). Momentum indicators are constructive - RSI around 54.5 and MACD showing bullish momentum - suggesting a near-term base rather than a fresh downtrend. Short interest and short volume have been elevated through June, with recent settlement-level short interest north of 7.5 million shares and multiple sessions of heavy short volume. That raises the risk of further headline-driven moves, but it also sets up the possibility of a sharp recovery if negative pressure eases.
Valuation framing - why $46 can look like a tactical bargain
On headline multiples MMYT looks expensive - EV/Sales ~14x and price-to-sales ~14.3x are premium territory. However, those multiples reflect expected growth and margin expansion in an addressable Indian travel market. The stock’s 52-week trading range and prior high near $105 demonstrate the market’s willingness to re-rate the share price when confidence in growth and governance returns. If you believe the company can arrest margin declines, extract synergies from corporate acquisitions (like Happay), and scale higher-margin services aided by AI-led product enhancements, then the current pullback is a timing opportunity rather than a secular downgrade.
Put differently - this is a trade on de-risking of headlines and recovery in booking volumes, not a pure value buy. If you want cheap valuation relative to peers, this is not the ticket today. If you want to buy optionality on travel normalization and a path back to materially better margins, the current price offers a measured entry.
Catalysts to watch (2-5)
- Regulatory clarity - any formal resolution or favorable public guidance addressing the March short-seller allegations will materially reduce headline risk and could spark a relief rally.
- Booking volumes - a return to sequential improvement in air and hotel bookings will validate demand recovery and lift revenue estimates.
- Corporate revenue growth - integration of Happay and cross-selling into over 900 corporate clients provides a near-term margin tailwind if adoption accelerates.
- Product upgrades - the OpenAI collaboration could improve conversion and average booking values if it increases discovery, personalization, and multi-language engagement.
Trade plan - actionable, with price points and timing
| Action | Price | Horizon | Risk Level |
|---|---|---|---|
| Enter long | $46.16 | Mid term (45 trading days) | Medium |
| Stop loss | $40.00 | ||
| Target | $60.00 | Exit or reassess at target | Review if target hit |
Rationale for sizing and timing: the mid-term window of 45 trading days captures the likely timeframe for travel seasonality improvements, early-cycle sentiment shifts after negative reports, and potential corporate client contribution signals. The stop at $40 caps the downside to a level that signals continued structural problems if broken - namely, persistent loss of market share, regulatory fines, or demonstrable accounting irregularities. The target of $60 is a realistic retracement objective that would reflect partial re-rating toward prior multiples without assuming a full recovery to the $100+ levels of last year.
Risks and counterarguments
- Regulatory or legal downside - The March report accuses the company of regulatory violations. A damaging regulatory ruling, fines, or injunctions could materially impair revenues and investor confidence.
- Accounting concerns - If subsequent audits or disclosures reveal material restatements or a large discrepancy between adjusted and IFRS profits, the stock could reprice much lower.
- Slower-than-expected travel recovery - A macro slowdown or weaker booking trends would delay profit recovery and leave current multiples exposed.
- Competitive pressure - Loss of market share to rivals or smaller aggregators could compress take rates and margins.
- High valuation - Current EV/Sales near 14x requires growth and margin improvement to justify the price - anything short of that invites multiple compression.
Counterargument: One credible bearish case is that the short-seller report uncovers real governance issues, forcing larger-than-expected restatements and regulatory fines. That scenario would validate the market's discounted valuation and argue for further downside below the March lows. I acknowledge this risk - which is why I set a hard $40 stop and size the position as a tactical trade, not a core buy-and-forget.
What would change my mind
I will reassess or flip to neutral/negative if any of the following happens: (1) a formal regulatory finding or criminal referral; (2) confirmed material accounting restatements exceeding the stop-loss economics; (3) a persistent sequential decline in bookings for two consecutive quarters; or (4) loss of key corporate clients that undermines the Happay integration thesis. Conversely, I would become more bullish if management transparently addresses allegations, delivers sequential revenue and margin improvement, and shows evidence that AI/product upgrades are lifting conversion and AOVs.
Conclusion
MakeMyTrip’s pullback has turned a high-growth but headline-sensitive story into a tactical trade setup. The company’s scale in India, corporate push, and product investments provide a plausible path back to stronger profitability. At $46.16 the risk-reward is attractive for a mid-term trade - but only if you manage risk tightly around $40 and monitor regulatory developments closely. This is a buy-the-dip idea, not a blind long. If the company clears the biggest headline risks and booking demand stabilizes, the stock can re-rate toward the $60 area within the planned 45 trading-day horizon. If those conditions don’t materialize, the stop-loss will limit capital at risk and force a re-evaluation.
Recent headlines to keep on your radar
- 03/30/2026 - Short-seller report alleges regulatory violations and accounting concerns.
- 02/18/2026 - OpenAI collaboration announced to enhance discovery and engagement.
- 11/18/2024 - Acquisition of Happay to boost corporate travel solutions.